Cover Image
市場調查報告書

北美的感染疾病診斷藥市場未來展望

North America Infectious Diagnostics Market Outlook to 2024

出版商 GlobalData 商品編碼 347959
出版日期 內容資訊 英文 596 Pages
訂單完成後即時交付
價格
Back to Top
北美的感染疾病診斷藥市場未來展望 North America Infectious Diagnostics Market Outlook to 2024
出版日期: 2017年12月01日 內容資訊: 英文 596 Pages
簡介

本報告提供北美各國 (美國·加拿大·墨西哥) 的各種感染疾病診斷藥市場相關分析,提供您整體市場規模 (以金額為準) 的實際成果值·預測值的動向,及各企業·各銷售管道的市場佔有率結構,各國市場詳細趨勢,主要企業簡介,主要的開發中產品現況 (開發平台實驗的進展階段等),近來市場主要動向等相關調查。

第1章 目錄

第2章 簡介

  • 本報告的問題的認知
  • 感染疾病診斷藥市場明細
  • 本報告分析範圍

第3章 北美各國的感染疾病診斷藥市場

  • 市場收益額趨勢預測 (總計15年份)
  • 市場收益額比較:各類別 (總計15年份)
  • 市場收益額的實際成果值 (過去8年份)
  • 市場收益額的預測值 (今後8年份)
  • 各企業的市場佔有率 (以收益為準)

第4章 加拿大的感染疾病診斷藥市場

  • 市場收益額的實際成果值 (過去8年份)
  • 市場收益額的預測值 (今後8年份)
    • 感染疾病快速診斷·POC (照護現場) 產品的市場:實際成果值 (過去8年份)
    • 感染疾病快速診斷·POC (照護現場) 產品的市場:預測值 (今後8年份)
  • 各流通管道的市場佔有率 (以收益為準)
  • 各企業的市場佔有率 (以收益為準)

第5章 墨西哥的感染疾病診斷藥市場

第6章 美國的感染疾病診斷藥市場

第7章 主要企業概要

  • Hologic, Inc.
    • 企業概要
  • Abbott Laboratories
  • Qiagen N.V.
  • F. Hoffmann-La Roche Ltd.
  • Becton, Dickinson and Company
  • Siemens Healthcare
  • Danaher Corporation
  • Alere Inc.
  • bioMerieux S.A.
  • DiaSorin S.p.A
  • Cepheid

第8章 感染疾病診斷藥市場開發中產品

第9章 資本交易環境

  • patonashippu (產業聯盟) (1件)

第10章 近來的市場趨勢

  • 企業宣傳 (企業通訊) (全30件)
  • 公佈財報 (全71件)
  • 政府·公共機關相關趨勢 (1件)
  • 法規·規定相關的動向 (全4件)
  • 其他重要的動向 (全10件)
  • 產品新聞 (全4件)
  • 策略·產業計畫 (全8件)

第11章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDMECR0750DB

GlobalData's new report, North America Infectious Diagnostics Market Outlook to 2024, provides key market data on the North America Infectious Diagnostics market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Bacteriology, Chlamydia trichomatis Diagnostic Test Kits, Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests, Hepatitis Test Kits, Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests, Infectious Diagnostics Multiple Parameter Test Kits, Infectious Diagnostics Rapid Tests & POC, Mycobacterium tuberculosis Diagnostic Tests, Nucleic Acid Testing Extraction Instruments, Other Virology, Parasitology & Mycology, Polymerase Chain Reaction (PCR) Systems, Post Streptococcus pyogenes Diagnostic Tests, Retrovirus Tests and Treponema pallidum Diagnostic Tests.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Infectious Diagnostics market segments - Bacteriology, Chlamydia trichomatis Diagnostic Test Kits, Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests, Hepatitis Test Kits, Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests, Infectious Diagnostics Multiple Parameter Test Kits, Infectious Diagnostics Rapid Tests & POC, Mycobacterium tuberculosis Diagnostic Tests, Nucleic Acid Testing Extraction Instruments, Other Virology, Parasitology & Mycology Polymerase Chain Reaction (PCR) Systems, Post Streptococcus pyogenes Diagnostic Tests, Retrovirus Tests and Treponema pallidum Diagnostic Tests.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2010 to 2017 and forecast to 2024.
  • 2017 company shares and distribution shares data for each of the market segments.
  • Global corporate-level profiles of key companies operating within the North America Infectious Diagnostics market.
  • Key players covered include Abbott Laboratories, F. Hoffmann-La Roche Ltd, Hologic Inc and Siemens Healthcare GmbH.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 4
  • 1.2 List of Figures 8

2 Introduction 13

  • 2.1 What Is This Report About? 13
  • 2.2 Infectious Diagnostics Market Segmentation 13
  • 2.3 Definitions of Markets Covered in the Report 15

3 Infectious Diagnostics Market, North America 20

  • 3.1 Infectious Diagnostics Market, North America, Revenue ($m), 2010-2024 20
  • 3.2 Infectious Diagnostics Market, North America, Category Comparison by Revenue ($m), 2010-2024 22
  • 3.3 Infectious Diagnostics Market, North America, Revenue ($m), 2010-2017 24
  • 3.4 Infectious Diagnostics Market, North America, Revenue ($m), 2017-2024 27
  • 3.5 Infectious Diagnostics Market, North America, Volume (Units), 2010-2024 30
  • 3.6 Infectious Diagnostics Market, North America, Volume (Units), 2010-2017 32
  • 3.7 Infectious Diagnostics Market, North America, Volume (Units), 2017-2024 35
  • 3.8 Infectious Diagnostics Market, North America, Company Share by Revenue ($m), 2017 38

4 Infectious Diagnostics Market, Canada 40

  • 4.1 Infectious Diagnostics Market, Canada, Revenue ($m), 2010-2017 40
  • 4.2 Infectious Diagnostics Market, Canada, Revenue ($m), 2017-2024 43
  • 4.3 Infectious Diagnostics Market, Canada, Volume (Units), 2010-2017 90
  • 4.4 Infectious Diagnostics Market, Canada, Volume (Units), 2017-2024 93
  • 4.5 Infectious Diagnostics Market, Canada, Average Price ($), 2010-2024 142
  • 4.6 Infectious Diagnostics Market, Canada, Distribution Share by Revenue ($m), 150
  • 4.7 Infectious Diagnostics Market, Canada, Company Share by Revenue ($m), 2017 151

5 Infectious Diagnostics Market, Mexico 153

  • 5.1 Infectious Diagnostics Market, Mexico, Revenue ($m), 2010-2017 153
  • 5.2 Infectious Diagnostics Market, Mexico, Revenue ($m), 2017-2024 156
  • 5.3 Infectious Diagnostics Market, Mexico, Volume (Units), 2010-2017 203
  • 5.4 Infectious Diagnostics Market, Mexico, Volume (Units), 2017-2024 206
  • 5.5 Infectious Diagnostics Market, Mexico, Average Price ($), 2010-2024 255
  • 5.6 Infectious Diagnostics Market, Mexico, Distribution Share by Revenue ($m), 2017 261
  • 5.7 Infectious Diagnostics Market, Mexico, Company Share by Revenue ($m), 2017 262

6 Infectious Diagnostics Market, United States 264

  • 6.1 Infectious Diagnostics Market, United States, Revenue ($m), 2010-2017 264
  • 6.2 Infectious Diagnostics Market, United States, Revenue ($m), 2017-2024 267
  • 6.3 Infectious Diagnostics Market, United States, Volume (Units), 2010-2017 314
  • 6.4 Infectious Diagnostics Market, United States, Volume (Units), 2017-2024 317
  • 6.5 Infectious Diagnostics Market, United States, Average Price ($), 2010-2024 366
  • 6.6 Infectious Diagnostics Market, United States, Distribution Share by Revenue ($m), 2017 373
  • 6.7 Infectious Diagnostics Market, United States, Company Share by Revenue ($m), 2017 374

7 Overview of Key Companies in North America Infectious Diagnostics Market 376

  • 7.1 Abbott Laboratories 376
  • 7.2 F. Hoffmann-La Roche Ltd 376
  • 7.3 Hologic Inc 376
  • 7.4 Qiagen NV 377
  • 7.5 Siemens Healthcare GmbH 377
  • 7.6 Alere Inc 377
  • 7.7 Beckman Coulter Inc 377
  • 7.8 Bio-Rad Laboratories Inc 378
  • 7.9 Becton Dickinson and Co 378
  • 7.10 Cepheid 378
  • 7.11 DiaSorin S.p.A 378
  • 7.12 bioMerieux SA 379
  • 7.13 Thermo Fisher Scientific Inc 379

8 Infectious Diagnostics Market Pipeline Products 380

9 Recent Developments 392

  • 9.1 Corporate Communications 392
  • 9.2 Financial Announcements 419
  • 9.3 Government and Public Interest 546
  • 9.4 Legal And Regulatory 549
  • 9.5 Other Significant Developments 555
  • 9.6 Product News 566
  • 9.7 Strategy And Business Planning 578

10 Appendix 580

  • 10.1 Research Methodology 581
  • 10.2 GlobalData Consulting 585
  • 10.3 Contact Us 586
  • 10.4 Disclaimer 586

List of Tables

1.1 List of Tables

  • Table 1: Infectious Diagnostics Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2010-2024 31
  • Table 2: Infectious Diagnostics Market, North America, Category Comparison by Revenue ($m), USD Constant, 2010-2024 33
  • Table 3: Infectious Diagnostics Market, North America, Revenue ($m), Historic, USD Constant, 2010-2017 35
  • Table 4: Infectious Diagnostics Market, North America, Revenue ($m), Forecast, USD Constant, 2017-2024 38
  • Table 5: Infectious Diagnostics Market, North America, Volume (Units), 2010-2024 41
  • Table 6: Infectious Diagnostics Market, North America, Volume (Units), Historic, 2010-2017 43
  • Table 7: Infectious Diagnostics Market, North America, Volume (Units), Forecast, 2017-2024 46
  • Table 8: Infectious Diagnostics Market, North America, Company Share by Revenue ($m), USD Constant, 2017 49
  • Table 9: Infectious Diagnostics Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 51
  • Table 10: Infectious Diagnostics Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 54
  • Table 11: Chlamydia trichomatis Diagnostic Test Kits Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 57
  • Table 12: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 59
  • Table 13: Hepatitis Test Kits Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 61
  • Table 14: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 63
  • Table 15: Infectious Diagnostics Multiple Parameter Test Kits Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 65
  • Table 16: Infectious Diagnostics Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 67
  • Table 17: Mycobacterium tuberculosis Diagnostic Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 69
  • Table 18: Polymerase Chain Reaction (PCR) Systems Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 71
  • Table 19: Post Streptococcus pyogenes Diagnostic Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 73
  • Table 20: Retrovirus Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 75
  • Table 21: Treponema pallidum Diagnostic Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 77
  • Table 22: Chlamydia trichomatis Diagnostic Test Kits Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 79
  • Table 23: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 81
  • Table 24: Hepatitis Test Kits Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 83
  • Table 25: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 85
  • Table 26: Infectious Diagnostics Multiple Parameter Test Kits Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 87
  • Table 27: Infectious Diagnostics Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 89
  • Table 28: Mycobacterium tuberculosis Diagnostic Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 91
  • Table 29: Polymerase Chain Reaction (PCR) Systems Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 93
  • Table 30: Post Streptococcus pyogenes Diagnostic Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 95
  • Table 31: Retrovirus Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 97
  • Table 32: Treponema pallidum Diagnostic Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 99
  • Table 33: Infectious Diagnostics Market, Canada, Volume (Units), Historic, 2010-2017 101
  • Table 34: Infectious Diagnostics Market, Canada, Volume (Units), Forecast, 2017-2024 104
  • Table 35: Chlamydia trichomatis Diagnostic Test Kits Market, Canada, Volume (Units), Historic, 2010-2017 107
  • Table 36: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Canada, Volume (Units), Historic, 2010-2017 109
  • Table 37: Hepatitis Test Kits Market, Canada, Volume (Units), Historic, 2010-2017 111
  • Table 38: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Canada, Volume (Units), Historic, 2010-2017 113
  • Table 39: Infectious Diagnostics Multiple Parameter Test Kits Market, Canada, Volume (Units), Historic, 2010-2017 115
  • Table 40: Infectious Diagnostics Rapid Tests & POC Market, Canada, Volume (Units), Historic, 2010-2017 117
  • Table 41: Mycobacterium tuberculosis Diagnostic Tests Market, Canada, Volume (Units), Historic, 2010-2017 119
  • Table 42: Polymerase Chain Reaction (PCR) Systems Market, Canada, Volume (Units), Historic, 2010-2017 121
  • Table 43: Post Streptococcus pyogenes Diagnostic Tests Market, Canada, Volume (Units), Historic, 2010-2017 123
  • Table 44: Retrovirus Tests Market, Canada, Volume (Units), Historic, 2010-2017 125
  • Table 45: Treponema pallidum Diagnostic Tests Market, Canada, Volume (Units), Historic, 2010-2017 127
  • Table 46: Chlamydia trichomatis Diagnostic Test Kits Market, Canada, Volume (Units), Forecast, 2017-2024 130
  • Table 47: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Canada, Volume (Units), Forecast, 2017-2024 132
  • Table 48: Hepatitis Test Kits Market, Canada, Volume (Units), Forecast, 2017-2024 134
  • Table 49: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Canada, Volume (Units), Forecast, 2017-2024 136
  • Table 50: Infectious Diagnostics Multiple Parameter Test Kits Market, Canada, Volume (Units), Forecast, 2017-2024 138
  • Table 51: Infectious Diagnostics Rapid Tests & POC Market, Canada, Volume (Units), Forecast, 2017-2024 140
  • Table 52: Mycobacterium tuberculosis Diagnostic Tests Market, Canada, Volume (Units), Forecast, 2017-2024 142
  • Table 53: Polymerase Chain Reaction (PCR) Systems Market, Canada, Volume (Units), Forecast, 2017-2024 144
  • Table 54: Post Streptococcus pyogenes Diagnostic Tests Market, Canada, Volume (Units), Forecast, 2017-2024 146
  • Table 55: Retrovirus Tests Market, Canada, Volume (Units), Forecast, 2017-2024 148
  • Table 56: Treponema pallidum Diagnostic Tests Market, Canada, Volume (Units), Forecast, 2017-2024 150
  • Table 57: Infectious Diagnostics Market, Canada, Average Price ($) Historic, 2010-2017 152
  • Table 58: Infectious Diagnostics Market, Canada, Average Price ($), Forecast, 2017-2024 156
  • Table 59: Infectious Diagnostics Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2017 160
  • Table 60: Infectious Diagnostics Market, Canada, Company Share by Revenue ($m), USD Constant, 2017 162
  • Table 61: Infectious Diagnostics Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 164
  • Table 62: Infectious Diagnostics Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 167
  • Table 63: Chlamydia trichomatis Diagnostic Test Kits Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 170
  • Table 64: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 172
  • Table 65: Hepatitis Test Kits Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 174
  • Table 66: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 176
  • Table 67: Infectious Diagnostics Multiple Parameter Test Kits Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 178
  • Table 68: Infectious Diagnostics Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 180
  • Table 69: Mycobacterium tuberculosis Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 182
  • Table 70: Polymerase Chain Reaction (PCR) Systems Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 184
  • Table 71: Post Streptococcus pyogenes Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 186
  • Table 72: Retrovirus Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 188
  • Table 73: Treponema pallidum Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 190
  • Table 74: Chlamydia trichomatis Diagnostic Test Kits Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 192
  • Table 75: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 194
  • Table 76: Hepatitis Test Kits Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 196
  • Table 77: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 198
  • Table 78: Infectious Diagnostics Multiple Parameter Test Kits Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 200
  • Table 79: Infectious Diagnostics Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 202
  • Table 80: Mycobacterium tuberculosis Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 204
  • Table 81: Polymerase Chain Reaction (PCR) Systems Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 206
  • Table 82: Post Streptococcus pyogenes Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 208
  • Table 83: Retrovirus Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 210
  • Table 84: Treponema pallidum Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 212
  • Table 85: Infectious Diagnostics Market, Mexico, Volume (Units), Historic, 2010-2017 214
  • Table 86: Infectious Diagnostics Market, Mexico, Volume (Units), Forecast, 2017-2024 217
  • Table 87: Chlamydia trichomatis Diagnostic Test Kits Market, Mexico, Volume (Units), Historic, 2010-2017 220
  • Table 88: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Mexico, Volume (Units), Historic, 2010-2017 222
  • Table 89: Hepatitis Test Kits Market, Mexico, Volume (Units), Historic, 2010-2017 224
  • Table 90: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Mexico, Volume (Units), Historic, 2010-2017 226
  • Table 91: Infectious Diagnostics Multiple Parameter Test Kits Market, Mexico, Volume (Units), Historic, 2010-2017 228
  • Table 92: Infectious Diagnostics Rapid Tests & POC Market, Mexico, Volume (Units), Historic, 2010-2017 230
  • Table 93: Mycobacterium tuberculosis Diagnostic Tests Market, Mexico, Volume (Units), Historic, 2010-2017 232
  • Table 94: Polymerase Chain Reaction (PCR) Systems Market, Mexico, Volume (Units), Historic, 2010-2017 234
  • Table 95: Post Streptococcus pyogenes Diagnostic Tests Market, Mexico, Volume (Units), Historic, 2010-2017 236
  • Table 96: Retrovirus Tests Market, Mexico, Volume (Units), Historic, 2010-2017 238
  • Table 97: Treponema pallidum Diagnostic Tests Market, Mexico, Volume (Units), Historic, 2010-2017 240
  • Table 98: Chlamydia trichomatis Diagnostic Test Kits Market, Mexico, Volume (Units), Forecast, 2017-2024 243
  • Table 99: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 245
  • Table 100: Hepatitis Test Kits Market, Mexico, Volume (Units), Forecast, 2017-2024 247
  • Table 101: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 249
  • Table 102: Infectious Diagnostics Multiple Parameter Test Kits Market, Mexico, Volume (Units), Forecast, 2017-2024 251
  • Table 103: Infectious Diagnostics Rapid Tests & POC Market, Mexico, Volume (Units), Forecast, 2017-2024 253
  • Table 104: Mycobacterium tuberculosis Diagnostic Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 255
  • Table 105: Polymerase Chain Reaction (PCR) Systems Market, Mexico, Volume (Units), Forecast, 2017-2024 257
  • Table 106: Post Streptococcus pyogenes Diagnostic Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 259
  • Table 107: Retrovirus Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 261
  • Table 108: Treponema pallidum Diagnostic Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 263
  • Table 109: Infectious Diagnostics Market, Mexico, Average Price ($) Historic, 2010-2017 265
  • Table 110: Infectious Diagnostics Market, Mexico, Average Price ($), Forecast, 2017-2024 268
  • Table 111: Infectious Diagnostics Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2017 271
  • Table 112: Infectious Diagnostics Market, Mexico, Company Share by Revenue ($m), USD Constant, 2017 273
  • Table 113: Infectious Diagnostics Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 275
  • Table 114: Infectious Diagnostics Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 278
  • Table 115: Chlamydia trichomatis Diagnostic Test Kits Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 281
  • Table 116: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 283
  • Table 117: Hepatitis Test Kits Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 285
  • Table 118: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 287
  • Table 119: Infectious Diagnostics Multiple Parameter Test Kits Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 289
  • Table 120: Infectious Diagnostics Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 291
  • Table 121: Mycobacterium tuberculosis Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 293
  • Table 122: Polymerase Chain Reaction (PCR) Systems Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 295
  • Table 123: Post Streptococcus pyogenes Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 297
  • Table 124: Retrovirus Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 299
  • Table 125: Treponema pallidum Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 301
  • Table 126: Chlamydia trichomatis Diagnostic Test Kits Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 303
  • Table 127: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 305
  • Table 128: Hepatitis Test Kits Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 307
  • Table 129: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 309
  • Table 130: Infectious Diagnostics Multiple Parameter Test Kits Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 311
  • Table 131: Infectious Diagnostics Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 313
  • Table 132: Mycobacterium tuberculosis Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 315
  • Table 133: Polymerase Chain Reaction (PCR) Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 317
  • Table 134: Post Streptococcus pyogenes Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 319
  • Table 135: Retrovirus Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 321
  • Table 136: Treponema pallidum Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 323
  • Table 137: Infectious Diagnostics Market, United States, Volume (Units), Historic, 2010-2017 325
  • Table 138: Infectious Diagnostics Market, United States, Volume (Units), Forecast, 2017-2024 328
  • Table 139: Chlamydia trichomatis Diagnostic Test Kits Market, United States, Volume (Units), Historic, 2010-2017 331
  • Table 140: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, United States, Volume (Units), Historic, 2010-2017 333
  • Table 141: Hepatitis Test Kits Market, United States, Volume (Units), Historic, 2010-2017 335
  • Table 142: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, United States, Volume (Units), Historic, 2010-2017 337
  • Table 143: Infectious Diagnostics Multiple Parameter Test Kits Market, United States, Volume (Units), Historic, 2010-2017 339
  • Table 144: Infectious Diagnostics Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 341
  • Table 145: Mycobacterium tuberculosis Diagnostic Tests Market, United States, Volume (Units), Historic, 2010-2017 343
  • Table 146: Polymerase Chain Reaction (PCR) Systems Market, United States, Volume (Units), Historic, 2010-2017 345
  • Table 147: Post Streptococcus pyogenes Diagnostic Tests Market, United States, Volume (Units), Historic, 2010-2017 347
  • Table 148: Retrovirus Tests Market, United States, Volume (Units), Historic, 2010-2017 349
  • Table 149: Treponema pallidum Diagnostic Tests Market, United States, Volume (Units), Historic, 2010-2017 351
  • Table 150: Chlamydia trichomatis Diagnostic Test Kits Market, United States, Volume (Units), Forecast, 2017-2024 354
  • Table 151: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, United States, Volume (Units), Forecast, 2017-2024 356
  • Table 152: Hepatitis Test Kits Market, United States, Volume (Units), Forecast, 2017-2024 358
  • Table 153: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, United States, Volume (Units), Forecast, 2017-2024 360
  • Table 154: Infectious Diagnostics Multiple Parameter Test Kits Market, United States, Volume (Units), Forecast, 2017-2024 362
  • Table 155: Infectious Diagnostics Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 364
  • Table 156: Mycobacterium tuberculosis Diagnostic Tests Market, United States, Volume (Units), Forecast, 2017-2024 366
  • Table 157: Polymerase Chain Reaction (PCR) Systems Market, United States, Volume (Units), Forecast, 2017-2024 368
  • Table 158: Post Streptococcus pyogenes Diagnostic Tests Market, United States, Volume (Units), Forecast, 2017-2024 370
  • Table 159: Retrovirus Tests Market, United States, Volume (Units), Forecast, 2017-2024 372
  • Table 160: Treponema pallidum Diagnostic Tests Market, United States, Volume (Units), Forecast, 2017-2024 374
  • Table 161: Infectious Diagnostics Market, United States, Average Price ($) Historic, 2010-2017 376
  • Table 162: Infectious Diagnostics Market, United States, Average Price ($), Forecast, 2017-2024 380
  • Table 163: Infectious Diagnostics Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 383
  • Table 164: Infectious Diagnostics Market, United States, Company Share by Revenue ($m), USD Constant, 2017 385
  • Table 165: Infectious Diagnostics Market Pipeline Products 390
  • Table 166: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 593

List of Figures

1.2 List of Figures

  • Figure 1: Infectious Diagnostics Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2010-2024 30
  • Figure 2: Infectious Diagnostics Market, North America, Category Comparison by Revenue ($m), USD Constant, 2010-2024 32
  • Figure 3: Infectious Diagnostics Market, North America, Revenue ($m), Historic, USD Constant, 2010-2017 34
  • Figure 4: Infectious Diagnostics Market, North America, Revenue ($m), Forecast, USD Constant, 2017-2024 37
  • Figure 5: Infectious Diagnostics Market, North America, Volume (Units), 2010-2024 40
  • Figure 6: Infectious Diagnostics Market, North America, Volume (Units), Historic, 2010-2017 42
  • Figure 7: Infectious Diagnostics Market, North America, Volume (Units), Forecast, 2017-2024 45
  • Figure 8: Infectious Diagnostics Market, North America, Company Share (%) 2017 48
  • Figure 9: Infectious Diagnostics Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 50
  • Figure 10: Infectious Diagnostics Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 53
  • Figure 11: Chlamydia trichomatis Diagnostic Test Kits Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 56
  • Figure 12: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 58
  • Figure 13: Hepatitis Test Kits Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 60
  • Figure 14: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 62
  • Figure 15: Infectious Diagnostics Multiple Parameter Test Kits Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 64
  • Figure 16: Infectious Diagnostics Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 66
  • Figure 17: Mycobacterium tuberculosis Diagnostic Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 68
  • Figure 18: Polymerase Chain Reaction (PCR) Systems Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 70
  • Figure 19: Post Streptococcus pyogenes Diagnostic Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 72
  • Figure 20: Retrovirus Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 74
  • Figure 21: Treponema pallidum Diagnostic Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 76
  • Figure 22: Chlamydia trichomatis Diagnostic Test Kits Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 78
  • Figure 23: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 80
  • Figure 24: Hepatitis Test Kits Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 82
  • Figure 25: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 84
  • Figure 26: Infectious Diagnostics Multiple Parameter Test Kits Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 86
  • Figure 27: Infectious Diagnostics Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 88
  • Figure 28: Mycobacterium tuberculosis Diagnostic Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 90
  • Figure 29: Polymerase Chain Reaction (PCR) Systems Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 92
  • Figure 30: Post Streptococcus pyogenes Diagnostic Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 94
  • Figure 31: Retrovirus Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 96
  • Figure 32: Treponema pallidum Diagnostic Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 98
  • Figure 33: Infectious Diagnostics Market, Canada, Volume (Units), Historic, 2010-2017 100
  • Figure 34: Infectious Diagnostics Market, Canada, Volume (Units), Forecast, 2017-2024 103
  • Figure 35: Chlamydia trichomatis Diagnostic Test Kits Market, Canada, Volume (Units), Historic, 2010-2017 106
  • Figure 36: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Canada, Volume (Units), Historic, 2010-2017 108
  • Figure 37: Hepatitis Test Kits Market, Canada, Volume (Units), Historic, 2010-2017 110
  • Figure 38: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Canada, Volume (Units), Historic, 2010-2017 112
  • Figure 39: Infectious Diagnostics Multiple Parameter Test Kits Market, Canada, Volume (Units), Historic, 2010-2017 114
  • Figure 40: Infectious Diagnostics Rapid Tests & POC Market, Canada, Volume (Units), Historic, 2010-2017 116
  • Figure 41: Mycobacterium tuberculosis Diagnostic Tests Market, Canada, Volume (Units), Historic, 2010-2017 118
  • Figure 42: Polymerase Chain Reaction (PCR) Systems Market, Canada, Volume (Units), Historic, 2010-2017 120
  • Figure 43: Post Streptococcus pyogenes Diagnostic Tests Market, Canada, Volume (Units), Historic, 2010-2017 122
  • Figure 44: Retrovirus Tests Market, Canada, Volume (Units), Historic, 2010-2017 124
  • Figure 45: Treponema pallidum Diagnostic Tests Market, Canada, Volume (Units), Historic, 2010-2017 126
  • Figure 46: Chlamydia trichomatis Diagnostic Test Kits Market, Canada, Volume (Units), Forecast, 2017-2024 129
  • Figure 47: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Canada, Volume (Units), Forecast, 2017-2024 131
  • Figure 48: Hepatitis Test Kits Market, Canada, Volume (Units), Forecast, 2017-2024 133
  • Figure 49: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Canada, Volume (Units), Forecast, 2017-2024 135
  • Figure 50: Infectious Diagnostics Multiple Parameter Test Kits Market, Canada, Volume (Units), Forecast, 2017-2024 137
  • Figure 51: Infectious Diagnostics Rapid Tests & POC Market, Canada, Volume (Units), Forecast, 2017-2024 139
  • Figure 52: Mycobacterium tuberculosis Diagnostic Tests Market, Canada, Volume (Units), Forecast, 2017-2024 141
  • Figure 53: Polymerase Chain Reaction (PCR) Systems Market, Canada, Volume (Units), Forecast, 2017-2024 143
  • Figure 54: Post Streptococcus pyogenes Diagnostic Tests Market, Canada, Volume (Units), Forecast, 2017-2024 145
  • Figure 55: Retrovirus Tests Market, Canada, Volume (Units), Forecast, 2017-2024 147
  • Figure 56: Treponema pallidum Diagnostic Tests Market, Canada, Volume (Units), Forecast, 2017-2024 149
  • Figure 57: Infectious Diagnostics Market, Canada, Company Share (%) 2017 161
  • Figure 58: Infectious Diagnostics Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 163
  • Figure 59: Infectious Diagnostics Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 166
  • Figure 60: Chlamydia trichomatis Diagnostic Test Kits Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 169
  • Figure 61: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 171
  • Figure 62: Hepatitis Test Kits Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 173
  • Figure 63: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 175
  • Figure 64: Infectious Diagnostics Multiple Parameter Test Kits Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 177
  • Figure 65: Infectious Diagnostics Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 179
  • Figure 66: Mycobacterium tuberculosis Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 181
  • Figure 67: Polymerase Chain Reaction (PCR) Systems Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 183
  • Figure 68: Post Streptococcus pyogenes Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 185
  • Figure 69: Retrovirus Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 187
  • Figure 70: Treponema pallidum Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 189
  • Figure 71: Chlamydia trichomatis Diagnostic Test Kits Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 191
  • Figure 72: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 193
  • Figure 73: Hepatitis Test Kits Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 195
  • Figure 74: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 197
  • Figure 75: Infectious Diagnostics Multiple Parameter Test Kits Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 199
  • Figure 76: Infectious Diagnostics Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 201
  • Figure 77: Mycobacterium tuberculosis Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 203
  • Figure 78: Polymerase Chain Reaction (PCR) Systems Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 205
  • Figure 79: Post Streptococcus pyogenes Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 207
  • Figure 80: Retrovirus Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 209
  • Figure 81: Treponema pallidum Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 211
  • Figure 82: Infectious Diagnostics Market, Mexico, Volume (Units), Historic, 2010-2017 213
  • Figure 83: Infectious Diagnostics Market, Mexico, Volume (Units), Forecast, 2017-2024 216
  • Figure 84: Chlamydia trichomatis Diagnostic Test Kits Market, Mexico, Volume (Units), Historic, 2010-2017 219
  • Figure 85: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Mexico, Volume (Units), Historic, 2010-2017 221
  • Figure 86: Hepatitis Test Kits Market, Mexico, Volume (Units), Historic, 2010-2017 223
  • Figure 87: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Mexico, Volume (Units), Historic, 2010-2017 225
  • Figure 88: Infectious Diagnostics Multiple Parameter Test Kits Market, Mexico, Volume (Units), Historic, 2010-2017 227
  • Figure 89: Infectious Diagnostics Rapid Tests & POC Market, Mexico, Volume (Units), Historic, 2010-2017 229
  • Figure 90: Mycobacterium tuberculosis Diagnostic Tests Market, Mexico, Volume (Units), Historic, 2010-2017 231
  • Figure 91: Polymerase Chain Reaction (PCR) Systems Market, Mexico, Volume (Units), Historic, 2010-2017 233
  • Figure 92: Post Streptococcus pyogenes Diagnostic Tests Market, Mexico, Volume (Units), Historic, 2010-2017 235
  • Figure 93: Retrovirus Tests Market, Mexico, Volume (Units), Historic, 2010-2017 237
  • Figure 94: Treponema pallidum Diagnostic Tests Market, Mexico, Volume (Units), Historic, 2010-2017 239
  • Figure 95: Chlamydia trichomatis Diagnostic Test Kits Market, Mexico, Volume (Units), Forecast, 2017-2024 242
  • Figure 96: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 244
  • Figure 97: Hepatitis Test Kits Market, Mexico, Volume (Units), Forecast, 2017-2024 246
  • Figure 98: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 248
  • Figure 99: Infectious Diagnostics Multiple Parameter Test Kits Market, Mexico, Volume (Units), Forecast, 2017-2024 250
  • Figure 100: Infectious Diagnostics Rapid Tests & POC Market, Mexico, Volume (Units), Forecast, 2017-2024 252
  • Figure 101: Mycobacterium tuberculosis Diagnostic Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 254
  • Figure 102: Polymerase Chain Reaction (PCR) Systems Market, Mexico, Volume (Units), Forecast, 2017-2024 256
  • Figure 103: Post Streptococcus pyogenes Diagnostic Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 258
  • Figure 104: Retrovirus Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 260
  • Figure 105: Treponema pallidum Diagnostic Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 262
  • Figure 106: Infectious Diagnostics Market, Mexico, Company Share (%) 2017 272
  • Figure 107: Infectious Diagnostics Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 274
  • Figure 108: Infectious Diagnostics Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 277
  • Figure 109: Chlamydia trichomatis Diagnostic Test Kits Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 280
  • Figure 110: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 282
  • Figure 111: Hepatitis Test Kits Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 284
  • Figure 112: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 286
  • Figure 113: Infectious Diagnostics Multiple Parameter Test Kits Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 288
  • Figure 114: Infectious Diagnostics Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 290
  • Figure 115: Mycobacterium tuberculosis Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 292
  • Figure 116: Polymerase Chain Reaction (PCR) Systems Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 294
  • Figure 117: Post Streptococcus pyogenes Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 296
  • Figure 118: Retrovirus Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 298
  • Figure 119: Treponema pallidum Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 300
  • Figure 120: Chlamydia trichomatis Diagnostic Test Kits Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 302
  • Figure 121: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 304
  • Figure 122: Hepatitis Test Kits Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 306
  • Figure 123: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 308
  • Figure 124: Infectious Diagnostics Multiple Parameter Test Kits Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 310
  • Figure 125: Infectious Diagnostics Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 312
  • Figure 126: Mycobacterium tuberculosis Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 314
  • Figure 127: Polymerase Chain Reaction (PCR) Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 316
  • Figure 128: Post Streptococcus pyogenes Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 318
  • Figure 129: Retrovirus Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 320
  • Figure 130: Treponema pallidum Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 322
  • Figure 131: Infectious Diagnostics Market, United States, Volume (Units), Historic, 2010-2017 324
  • Figure 132: Infectious Diagnostics Market, United States, Volume (Units), Forecast, 2017-2024 327
  • Figure 133: Chlamydia trichomatis Diagnostic Test Kits Market, United States, Volume (Units), Historic, 2010-2017 330
  • Figure 134: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, United States, Volume (Units), Historic, 2010-2017 332
  • Figure 135: Hepatitis Test Kits Market, United States, Volume (Units), Historic, 2010-2017 334
  • Figure 136: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, United States, Volume (Units), Historic, 2010-2017 336
  • Figure 137: Infectious Diagnostics Multiple Parameter Test Kits Market, United States, Volume (Units), Historic, 2010-2017 338
  • Figure 138: Infectious Diagnostics Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 340
  • Figure 139: Mycobacterium tuberculosis Diagnostic Tests Market, United States, Volume (Units), Historic, 2010-2017 342
  • Figure 140: Polymerase Chain Reaction (PCR) Systems Market, United States, Volume (Units), Historic, 2010-2017 344
  • Figure 141: Post Streptococcus pyogenes Diagnostic Tests Market, United States, Volume (Units), Historic, 2010-2017 346
  • Figure 142: Retrovirus Tests Market, United States, Volume (Units), Historic, 2010-2017 348
  • Figure 143: Treponema pallidum Diagnostic Tests Market, United States, Volume (Units), Historic, 2010-2017 350
  • Figure 144: Chlamydia trichomatis Diagnostic Test Kits Market, United States, Volume (Units), Forecast, 2017-2024 353
  • Figure 145: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, United States, Volume (Units), Forecast, 2017-2024 355
  • Figure 146: Hepatitis Test Kits Market, United States, Volume (Units), Forecast, 2017-2024 357
  • Figure 147: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, United States, Volume (Units), Forecast, 2017-2024 359
  • Figure 148: Infectious Diagnostics Multiple Parameter Test Kits Market, United States, Volume (Units), Forecast, 2017-2024 361
  • Figure 149: Infectious Diagnostics Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 363
  • Figure 150: Mycobacterium tuberculosis Diagnostic Tests Market, United States, Volume (Units), Forecast, 2017-2024 365
  • Figure 151: Polymerase Chain Reaction (PCR) Systems Market, United States, Volume (Units), Forecast, 2017-2024 367
  • Figure 152: Post Streptococcus pyogenes Diagnostic Tests Market, United States, Volume (Units), Forecast, 2017-2024 369
  • Figure 153: Retrovirus Tests Market, United States, Volume (Units), Forecast, 2017-2024 371
  • Figure 154: Treponema pallidum Diagnostic Tests Market, United States, Volume (Units), Forecast, 2017-2024 373
  • Figure 155: Infectious Diagnostics Market, United States, Company Share (%) 2017 384
Back to Top